Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics – DIR HONGKONG

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Jul 25, 2025-

Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics – DIR HONGKONG

Open the article to view the coverage from dirhongkong.com

Swan EndoSurgical debuts to advance GI robotics

Olympus Corp., a global medical technology company, today announced that it has agreed to partner with investment firm Revival Healthcare Capital to drive advancements in endoluminal robotics. Together, Olympus and Revival plan to co-found Swan EndoSurgical Robotics. The new company will focus on developing a novel endoluminal robotic system for gastrointestinal (GI) patient care. The companies said they will jointly invest up to $458 million in…